Updated analysis by Mangold Insight
Today, Mangold Insight published an updated company analysis of Lumito. The company analysis in a commissioned analysis and is available here, but can also be accessed from Lumito’s website here. Please note that the company analysis is in Swedish. For further information, please contact: Mattias Lundin, CEO Lumito E-mail: ml@lumito.se Ph: +46 76 868 45 09 […]
Exhibiting at EACR Congress in Torino and Nordic Oncology Forum in Stockholm in June 2023
Continuing the company’s marketing work towards commercialization by igniting interest and awareness in potential customers and collaborators, Lumito will be exhibiting at the European Association for Cancer Research (EACR) 2023 in Torino, Italy 12-15 of June, as well as Nordic Oncology Forum in Stockholm 26-27 of June. “We look forward to showcasing our product and […]
Live demonstration of Lumito’s scanner confirmed problem-solving capabilities
We finally got to show our product, SCIZYS by Lumito, during a live demonstration where tissue images were scanned in Lumito's laboratory under the supervision of around ten researchers and pathologists from the Malmö/Lund area. The visitors saw the added value of our product and confirmed the problem that Lumito could potentially solve. Tommy Lidström, […]
Planning for the next strategic step after Europe – the US tissue diagnostics research market
Following the launch of SCIZYS, Lumito's solution for research laboratories operating in tissue diagnostics in Sweden, followed by the Nordic countries and the rest of Europe, the next strategic step is now being planned, a launch in the world's largest research market, the US. This growing market is estimated to be worth approximately USD 733 […]
Lumito on BioStock’s list of the 10 strongest life science stocks 2022
BioStock has listed this year's ten strongest Swedish life science stocks and taken a closer look at some companies to see what's behind the share price increases. Lumito is ranked third on the list: "Lumito rises ahead of market launch High up on this year's winners list we also find diagnostics company Lumito, […]
Reflections from the Digital Pathology & AI Congress. Lumito – New kid in town
Lumito participated with a booth of our own at the Digital Pathology & AI Congress in London in early December. The congress was attended by over 440 delegates and was held at a conference hotel at Heathrow. The delegates, primarily from Western Europe, were specifically interested in the digitalization of pathology with both research and […]
Lumitos presentation at BioStock Life Science Summit
Lumito's CEO Mattias Lundin presented the company and the upcoming product launch to the public in the well-attended Auditorium at Medicon Village in Lund. After the presentation, there was opportunity for Q&As which included delayed launch, possibilities for multiplexing and analysis of more biomarkers as well as whether there are plans to launch the product […]
The scientific article “Extracellular galectin 4 drives immune evasion and promotes T-cell apoptosis in pancreatic cancer” is now published in Cancer Immunology Research
The scientific article entitled "Extracellular galectin 4 drives immune evasion and promotes T-cell apoptosis in pancreatic cancer" is now published in the scientific journal Cancer Immunology Research. The main objective of the journal is to publish the best new findings from leading experts in chemistry, biology and clinical science. The paper is written by Daniel […]
Lumito AB publishes Quarterly Report 3, 2022
Financial overview of the third quarter July 1 to September 30, 2022 Net sales amounted to TSEK 0 (0). Result after taxes amounted to TSEK -6 815 (-6 073). Earnings per share before and after dilution amounted to SEK -0.04 (-0.07). Cash flow from operating activities after changes in working capital amounted to TSEK -9 […]
The pre-launch phase of SCIZYS by Lumito continues without interruption
The pre-launch phase, which started in Spring 2022, continues and is now intensified as planned. Lumito will be represented with its own stand at the Digital Pathology & AI Congress: Europe in London on December 7-8. The presence at the congress will be complemented by advertising and editorial in the international professional journal The Pathologist […]
